Lucid Diagnostics completes $70 million initial public offering

Lucid Diagnostics Inc., a company that produces esophageal cancer tests based on Case Western Reserve University and University Hospitals research, has complete

Related Keywords

Case Western Reserve University ,Ohio ,United States ,Marshallb Brown ,Joseph Willis ,Sandy Markowitz ,Ellery Sedgwick ,Jane Shiverick Tripp ,Daniel Simon ,Mukesh Jain ,Joe Willis ,Patricia Shiverick ,Stan Gerson ,Lishan Aklog ,Sanford Markowitz ,School Of Medicine ,University Hospitals ,National Cancer Institute ,Nasdaq ,University Hospitals Health System ,Betrnet Barrett Esophagus Translational Research Network ,Uh Seidman Cancer Center ,Lucid Diagnostics Inc ,Program Of Research Excellence ,Case Comprehensive Cancer Center ,Drug Administration ,University Hospitals Digestive Health Institute ,Chak At University Hospitals ,University Hospitals Seidman Cancer Center ,Technology Transfer Office ,University Hospitals Uh Seidman Cancer Center ,Case Western Reserve Technology Transfer Office ,University Professor ,Coulter Translational Research Partnership ,Pavmed Inc ,Nasdaq Global Market ,New York Based ,Case Western Reserve ,Breakthrough Device ,Medical Testing ,Drug Administration Cleared ,Ingalls Professor ,Cancer Genetics ,Seidman Cancer Center ,Amitabh Chak ,Master Clinician ,Cancer Center ,New York ,Research Excellence ,Esophagus Translational Research Network ,Case Coulter Translational Research Partnership ,Translational Science Collaborative ,Ohio Third Frontier ,Nottingham Spirk Design Collaborative ,Jane Shiverick ,Ellery Sedgwick Chair ,Distinguished Scientist ,Distinguished University Professor ,University Hospitals Health ,Western Reserve University ,Newswise ,Ancer Esophageal Cancer Test ,Cancer ,Healthcare ,University Hospitals Cleveland Medical Center ,